Search





Search





Markets
/
Stocks
/
cgtx
/

Cognition Therapeutics Inc

CGTX

Add to Watchlist

0.890USD

-0.026-2.88%

Close 07-31 16:00（ET）Quotes delayed by 15 min

79.09MMarket Cap

LossP/E TTM

Cognition Therapeutics Inc

0.890

-0.026-2.88%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CGTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Cognition Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

43.89%-5.54M

59.00%-3.44M

17.52%-5.65M

6.24%-5.62M

-36.35%-9.88M

-53.63%-8.38M

-64.65%-6.85M

-62.26%-6.00M

-167.80%-7.24M

46.43%-5.46M

-103925.00%-4.16M

31.01%-3.70M

9.47%-2.71M

-10183.17%-10.18M

99.80%-4.00K

-488.68%-5.36M

-287.05%-2.99M

121.04%101.00K

---2.05M

---910.00K

-245.66%-772.00K

---480.00K

--530.00K

Net income from continuing operations

46.11%-4.57M

57.37%-3.34M

50.39%-4.93M

4.36%-6.73M

7.33%-8.48M

3.67%-7.84M

-47.24%-9.94M

-48.98%-7.04M

-48.27%-9.15M

-57.10%-8.14M

-1.87%-6.75M

17.84%-4.73M

-60.81%-6.17M

29.39%-5.18M

-113.02%-6.63M

-286.04%-5.75M

-1821.08%-3.84M

-292.88%-7.34M

---3.11M

---1.49M

108.90%223.00K

---1.87M

---2.51M

Operating gains losses

-79.63%11.00K

-80.28%14.00K

-78.57%15.00K

-89.55%7.00K

-6.90%54.00K

7.58%71.00K

7.69%70.00K

9.84%67.00K

-3.33%58.00K

10.00%66.00K

8.33%65.00K

3.39%61.00K

7.14%60.00K

160.87%60.00K

145.83%59.00K

143.48%56.00K

-4.17%23.00K

--23.00K

--24.00K

-8.00%23.00K

--24.00K

--25.00K

Other non-cash items

733.33%57.00K

--47.00K

--46.00K

--54.00K

-104.62%-9.00K

100.00%0.00

-100.00%0.00

--0.00

-38.68%195.00K

---5.00K

--5.00K

--0.00

--318.00K

--0.00

----

-100.00%0.00

--0.00

--9.00K

-411.85%-421.00K

--20.00K

--135.00K

Change in working capital

32.20%-1.38M

51.62%-554.00K

-161.51%-1.30M

352.35%429.00K

-519.88%-2.03M

-173.73%-1.15M

46.51%2.12M

-203.57%-170.00K

-74.61%483.00K

126.04%1.55M

-74.98%1.45M

89.93%-56.00K

1018.84%1.90M

-366.49%-5.96M

17427.27%5.78M

-220.09%-556.00K

-291.67%-207.00K

124.70%2.24M

--33.00K

--463.00K

-96.41%108.00K

--996.00K

--3.00M

-Change in receivables

399.52%6.27M

-1274.67%-8.02M

1724.07%4.38M

32.66%-1.51M

-598.10%-2.09M

91.32%683.00K

-135.76%-270.00K

-185.46%-2.24M

-79.64%420.00K

131.21%357.00K

-1.56%755.00K

-56.49%-784.00K

490.72%2.06M

-4.47%-1.14M

-44.90%767.00K

-111.39%-501.00K

55.03%-528.00K

-154.10%-1.09M

--1.39M

---237.00K

-152.74%-1.17M

--2.02M

--2.23M

-Change in prepaid expenses

-32.00%136.00K

639.06%473.00K

-89.96%47.00K

-12.55%453.00K

-65.69%200.00K

-92.85%64.00K

128.29%468.00K

-37.14%518.00K

909.72%583.00K

-53.07%895.00K

139.42%205.00K

199.88%824.00K

45.45%-72.00K

4789.74%1.91M

-306.35%-520.00K

-43.48%-825.00K

-143.28%-132.00K

119.21%39.00K

--252.00K

---575.00K

1229.63%305.00K

---203.00K

---27.00K

-Change in payables and accrued expense

-9993.33%-7.57M

568.49%8.41M

-336.45%-5.44M

-64.41%614.00K

80.11%-75.00K

-397.84%-1.80M

242.56%2.30M

48.07%1.73M

---377.00K

--603.00K

--672.00K

--1.17M

----

-Change in other current assets

----

---1.73M

----

--1.42M

---1.42M

----

-Change in other current liabilities

---147.00K

-2584.31%-1.37M

26.79%-246.00K

799.24%916.00K

----

80.46%-51.00K

-130.14%-336.00K

89.94%-131.00K

-631.82%-117.00K

-197.03%-261.00K

-201.39%-146.00K

-528.99%-1.30M

-99.09%22.00K

268.13%269.00K

-3.36%144.00K

-127.06%-207.00K

1060.08%2.43M

67.68%-160.00K

--149.00K

--765.00K

---253.00K

---495.00K

--0.00

Cash from non-recurring investing activities

Cash from operating activities

43.89%-5.54M

59.00%-3.44M

17.52%-5.65M

6.24%-5.62M

-36.35%-9.88M

-53.63%-8.38M

-64.65%-6.85M

-62.26%-6.00M

-167.80%-7.24M

46.43%-5.46M

-103925.00%-4.16M

31.01%-3.70M

9.47%-2.71M

-10183.17%-10.18M

99.80%-4.00K

-488.68%-5.36M

-287.05%-2.99M

121.04%101.00K

---2.05M

---910.00K

-245.66%-772.00K

---480.00K

--530.00K

Investing cash flow

Net cash from continuing investing activities

----

-1000.00%-9.00K

----

-96.67%1.00K

-100.00%0.00

-83.33%3.00K

-100.00%0.00

200.00%30.00K

152.17%58.00K

350.00%18.00K

-69.40%41.00K

-62.96%10.00K

--23.00K

--4.00K

--134.00K

--27.00K

--0.00

-100.00%0.00

--0.00

--10.00K

Capital expenditures

----

-96.67%1.00K

-100.00%0.00

-83.33%3.00K

-100.00%0.00

200.00%30.00K

152.17%58.00K

350.00%18.00K

-69.40%41.00K

-62.96%10.00K

--23.00K

--4.00K

--134.00K

--27.00K

--0.00

-100.00%0.00

--0.00

--10.00K

Net cash flow from disposal of fixed assets

----

-1000.00%-9.00K

----

-96.67%1.00K

-100.00%0.00

-83.33%3.00K

-100.00%0.00

200.00%30.00K

152.17%58.00K

350.00%18.00K

-69.40%41.00K

-62.96%10.00K

--23.00K

--4.00K

--134.00K

--27.00K

--0.00

-100.00%0.00

--0.00

--10.00K

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

----

1000.00%9.00K

----

96.67%-1.00K

100.00%0.00

83.33%-3.00K

100.00%0.00

-200.00%-30.00K

-152.17%-58.00K

-350.00%-18.00K

69.40%-41.00K

62.96%-10.00K

---23.00K

---4.00K

---134.00K

---27.00K

--0.00

100.00%0.00

--0.00

---10.00K

Financing cash flow

Cash flow from continuous financing activities

-117.98%-233.00K

-94.68%605.00K

10209.12%33.92M

644.93%752.00K

-89.19%1.30M

366.63%11.38M

11066.67%329.00K

-106.59%-138.00K

120030.00%11.99M

-52.57%2.44M

-100.35%-3.00K

660.16%2.10M

89.01%-10.00K

-88.91%5.14M

190.43%869.00K

67.62%-374.00K

-101.02%-91.00K

10318.20%46.36M

---961.00K

---1.16M

136.81%8.96M

--445.00K

--3.78M

Net cash flow from debt Issuance/repayment

4.24%-113.00K

62.05%-74.00K

77.84%-41.00K

33.70%-120.00K

33.71%-118.00K

-8.94%-195.00K

13.95%-185.00K

13.81%-181.00K

14.01%-178.00K

12.68%-179.00K

46.38%-215.00K

46.97%-210.00K

47.46%-207.00K

23.51%-205.00K

---401.00K

---396.00K

---394.00K

-160.50%-268.00K

----

-100.00%0.00

--443.00K

--3.84M

Net cash flow from common stock issuance/repurchase

----

-93.52%750.00K

6726.76%33.93M

--877.00K

-88.11%1.46M

342.17%11.58M

134.43%497.00K

-100.00%0.00

--12.28M

-50.83%2.62M

--212.00K

--2.50M

----

-87.96%5.32M

----

--44.22M

----

Proceeds from stock option exercised by employees

--44.00K

--6.00K

282.35%65.00K

----

--0.00

--17.00K

--65.00K

----

-100.00%0.00

-91.05%23.00K

25300.00%1.27M

--22.00K

2064.29%303.00K

12750.00%257.00K

--5.00K

--0.00

--14.00K

--2.00K

--0.00

Proceeds from issuance of warrants

----

--0.00

----

--0.00

--34.00K

----

--0.00

----

Net cash flow from other financing activities

-256.52%-164.00K

---77.00K

---36.00K

77.27%-5.00K

56.60%-46.00K

--0.00

88.83%-22.00K

-153.81%-106.00K

----

---197.00K

--197.00K

-100.00%0.00

100.00%0.00

----

--2.15M

---966.00K

---1.19M

16358.18%8.94M

--0.00

---55.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-117.98%-233.00K

-94.68%605.00K

10209.12%33.92M

644.93%752.00K

-89.19%1.30M

366.63%11.38M

11066.67%329.00K

-106.59%-138.00K

120030.00%11.99M

-52.57%2.44M

-100.35%-3.00K

660.16%2.10M

89.01%-10.00K

-88.91%5.14M

190.43%869.00K

67.62%-374.00K

-101.02%-91.00K

10318.20%46.36M

---961.00K

---1.16M

136.81%8.96M

--445.00K

--3.78M

Net cash flow

Beginning cash balance

47.95%37.00M

80.92%39.82M

-59.50%11.56M

-52.62%16.43M

-16.42%25.01M

-33.24%22.01M

-23.28%28.53M

-10.66%34.67M

-28.01%29.92M

-29.27%32.97M

-18.75%37.19M

-24.65%38.81M

-24.05%41.56M

460.89%46.61M

305.05%45.77M

285.17%51.51M

954.56%54.72M

58.50%8.31M

--11.30M

--13.37M

79.55%5.19M

--5.24M

--2.89M

Current period cash flow changes

32.70%-5.78M

-194.16%-2.82M

533.39%28.27M

20.64%-4.87M

-280.69%-8.58M

198.39%3.00M

-54.51%-6.52M

-278.89%-6.14M

272.57%4.75M

39.64%-3.05M

-603.10%-4.22M

71.77%-1.62M

14.32%-2.75M

-110.88%-5.05M

128.06%839.00K

-176.80%-5.74M

-139.25%-3.21M

86046.30%46.41M

---2.99M

---2.07M

91.75%8.18M

---54.00K

--4.27M

Effect of exchange rate changes

----

-100.00%0.00

133.33%1.00K

66.67%-1.00K

300.00%4.00K

116.67%4.00K

-114.29%-3.00K

62.50%-3.00K

--1.00K

-26.32%-24.00K

--21.00K

---8.00K

100.00%0.00

---19.00K

---34.00K

Ending cash balance

90.07%31.23M

47.95%37.00M

80.92%39.82M

-59.50%11.56M

-52.62%16.43M

-16.42%25.01M

-33.24%22.01M

-23.28%28.53M

-10.66%34.67M

-28.01%29.92M

-29.27%32.97M

-18.75%37.19M

-24.65%38.81M

-24.05%41.56M

460.89%46.61M

305.05%45.77M

285.17%51.51M

954.56%54.72M

--8.31M

--11.30M

86.83%13.37M

--5.19M

--7.16M

Free cash flow

----

-52.81%-8.38M

-62.38%-6.85M

-61.55%-6.00M

-163.80%-7.24M

46.18%-5.49M

-15525.93%-4.22M

30.72%-3.71M

12.04%-2.75M

-13875.68%-10.19M

98.68%-27.00K

-489.12%-5.36M

-304.40%-3.12M

115.42%74.00K

---2.05M

---910.00K

-248.46%-772.00K

---480.00K

--520.00K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Cognition Therapeutics Inc Generate?



Cognition Therapeutics Inc generated -24.59M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Cognition Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Cognition Therapeutics Inc's operating cash flow increased by 13.65% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Cognition Therapeutics Inc's Financing Cash Flow Changed?



Cognition Therapeutics Inc used 36.57M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CGTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.